Company / Total Assets
RIGEL PHARMACEUTICALS INC Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$513.6M
FY2025
5-year range
$117.2M / $513.6M
FY2021-FY2025
Trend
+213.2%
vs FY2024
Sector context
#135 of 214
Health Care
What the data says
Total Assets changed +213% YoY in FY2025, a notable deviation from the 9-year average annual change of +36%.
Based on SEC 10-K filings.
$514M in FY2025 with a 5-year CAGR of +36.0%.
Improved from $117M to $514M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +56.4%
- 5-Year CAGR
- +36.0%
- 10-Year CAGR
- -
Sector benchmark
#135 of 214 in Health CareTop 63% of 214This company $513.6M Sector average $7.5B
▼
-93.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +36.0%, indicating consistent growth.
- In FY2025, total assets increased 213.2% year-over-year.
- Ranks #135 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $513.6M | +213.2% |
| FY2024 | $164.0M | +39.9% |
| FY2023 | $117.2M | -12.7% |
| FY2022 | $134.3M | -19.8% |
| FY2021 | $167.3M | +51.6% |
| FY2020 | $110.4M | -25.2% |
| FY2019 | $147.6M | +6.1% |
| FY2018 | $139.1M | +16.8% |
| FY2017 | $119.1M | +52.4% |
| FY2016 | $78.1M | -40.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026